Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak L Bhatt

Showing results (971-980 of 1,708) with videos related to

Pageof 171
Sort By:
The American Journal of Cardiology|January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
JACC. Cardiovascular Interventions|August 26, 2017
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data AnalysisRaffaele Piccolo, Fausto Feres, Alexandre Abizaid, et al.
Diabetes Care|March 16, 2021
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab TreatmentGregory G Schwartz, Michael Szarek, Vera A Bittner, et al.
American Heart Journal|September 29, 2021
Rationale and pathways forward in the implementation of coronary artery calcium-based enrichment of randomized trialsMiguel Cainzos-Achirica, Dixitha Anugula, Reed Mszar, et al.
Scientific Reports|March 15, 2022
Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillationTeresa Oliveras, Iolanda Lázaro, Ferran Rueda, et al.
Circulation|May 18, 2023
Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic StrokeShumei Man, Nicole Solomon, Brian Mac Grory, et al.
Clinical Cardiology|March 18, 2014
Choice of vein-harvest technique for coronary artery bypass grafting: rationale and design of the REGROUP trialMarco A Zenati, J Michael Gaziano, Joseph F Collins, et al.
The New England Journal of Medicine|April 1, 2014
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomesPhilip R Schauer, Deepak L Bhatt, John P Kirwan, et al.
Stroke|September 25, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular DiseaseMichiel H F Poorthuis, Steven H J Hageman, Aernoud T L Fiolet, et al.
Journal of the American College of Cardiology|April 23, 2013
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51C Michael Gibson, Anjan K Chakrabarti, Jessica Mega, et al.
Pageof 171

Showing results (971-980 of 1,708) with videos related to

Sort By:
Pageof 171
The American Journal of Cardiology|January 12, 2020
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)Jurrien M Ten Berg, Philippe Gabriel Steg, Deepak L Bhatt, et al.
JACC. Cardiovascular Interventions|August 26, 2017
Risk of Early Adverse Events After Clopidogrel Discontinuation in Patients Undergoing Short-Term Dual Antiplatelet Therapy: An Individual Participant Data AnalysisRaffaele Piccolo, Fausto Feres, Alexandre Abizaid, et al.
Diabetes Care|March 16, 2021
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab TreatmentGregory G Schwartz, Michael Szarek, Vera A Bittner, et al.
American Heart Journal|September 29, 2021
Rationale and pathways forward in the implementation of coronary artery calcium-based enrichment of randomized trialsMiguel Cainzos-Achirica, Dixitha Anugula, Reed Mszar, et al.
Scientific Reports|March 15, 2022
Circulating linoleic acid at the time of myocardial infarction and risk of primary ventricular fibrillationTeresa Oliveras, Iolanda Lázaro, Ferran Rueda, et al.
Circulation|May 18, 2023
Shorter Door-to-Needle Times Are Associated With Better Outcomes After Intravenous Thrombolytic Therapy and Endovascular Thrombectomy for Acute Ischemic StrokeShumei Man, Nicole Solomon, Brian Mac Grory, et al.
Clinical Cardiology|March 18, 2014
Choice of vein-harvest technique for coronary artery bypass grafting: rationale and design of the REGROUP trialMarco A Zenati, J Michael Gaziano, Joseph F Collins, et al.
The New England Journal of Medicine|April 1, 2014
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomesPhilip R Schauer, Deepak L Bhatt, John P Kirwan, et al.
Stroke|September 25, 2024
Prediction of Severe Baseline Asymptomatic Carotid Stenosis and Subsequent Risk of Stroke and Cardiovascular DiseaseMichiel H F Poorthuis, Steven H J Hageman, Aernoud T L Fiolet, et al.
Journal of the American College of Cardiology|April 23, 2013
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51C Michael Gibson, Anjan K Chakrabarti, Jessica Mega, et al.
Pageof 171